Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation

Completed · Phase 2

Conditions studied: Paroxysmal Atrial Fibrillation

In brief

This is a demonstration of safety and efficacy of the ablation for pulmonary vein isolation in the treatment of paroxysmal atrial fibrillation.

Key facts

Study ID

NCT00971204

Run by

CardioFocus

People needed

100

Starts

2009-09-01

Expected to finish

2012-06-01

Last updated by the study team

2016-08-01

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 to 70 years
• paroxysmal atrial fibrillation
• failure of at least one AAD
• others

You may not qualify if…

• overall good health as established by multiple criteria

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States
• Pacific Heart Institute — Santa Monica, California, United States
• William Beaumont Hospital — Royal Oak, Michigan, United States
• Mt. Sinai Hospital — New York, New York, United States
• University of Pennsylvania Health System — Philadelphia, Pennsylvania, United States
• Medical University of South Carolina — Charleston, South Carolina, United States
• Texas Cardiac Arrhythmia Research Foundation — Austin, Texas, United States
• The Methodist Hospital Research Institute — Houston, Texas, United States
• University Of Virginia Health System — Charlottesville, Virginia, United States
• Sentara Norfolk General Hospital — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.